Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A-BEP: Aprepitant + BEP in Testis Carcinoma
NCT00429754Phase 4Withdrawn
- Sponsor
- Radboud University Medical Center
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of aprepitant in nausea ((none)), Vomiting, sponsored by Radboud University Medical Center. Status: withdrawn.
02
Drugs
aprepitant
03
Conditions
nausea ((none))Vomiting
Beyond the preview
Go deeper on NCT00429754.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00429754.